Clifton NJ 多发性骨髓瘤临床试验
15项针对 多发性骨髓瘤的研究正在 Clifton及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
招募中4 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
招募中观察性研究
- Hackensack University Medical Center, Hackensack · 距离 7 英里
Mosaic Trial for Stem Cell Transplant Recipients
招募中
- Hackensack Meridian Health, Nutley · 距离 3 英里
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
招募中1/2 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
招募中1/2 期
- Research Site, Hackensack · 距离 7 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- Hackensack Meridian Health, Hackensack · 距离 7 英里
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
招募中2 期
- John Theurer Cancer Center, Hackensack · 距离 7 英里
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
招募中1 期
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · 距离 7 英里
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
招募中1/2 期
- Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
招募中1 期
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 距离 7 英里
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
招募中3 期
- GSK Investigational Site, Hackensack · 距离 7 英里
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
招募中1 期
- Hackensack Meridian John Theurer Cancer Center, Hackensack · 距离 7 英里
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
招募中1/2 期
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 距离 7 英里
其他城市的 多发性骨髓瘤试验
- New York City, NY59 项研究
- Boston, MA45 项研究
- Atlanta, GA42 项研究
- Houston, TX39 项研究
- Durham, NC36 项研究
- Nashville, TN31 项研究
- Denver, CO26 项研究
- St. Louis, MO26 项研究
- Rochester, MN25 项研究
- Columbus, OH25 项研究
- Chicago, IL24 项研究
- Milwaukee, WI23 项研究
Clifton的其他研究
- 非小细胞肺癌23 项研究
- 癌症（所有类型）13 项研究
- 前列腺癌12 项研究
- 急性髓系白血病11 项研究
- 卵巢癌11 项研究
- 转移性癌症11 项研究
- 乳腺癌11 项研究
- 结直肠癌9 项研究
- 肺癌9 项研究
- 心力衰竭9 项研究
- 白血病8 项研究
- 血液癌症8 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。